FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4282936139> ?p ?o ?g. }

• W4282936139 endingPage "3725" @default.
• W4282936139 startingPage "3725" @default.
• W4282936139 abstract "Abstract Introduction: SETD2 encodes a histone H3-K36 methyltransferase which is frequently inactivated in clear cell renal carcinomas (ccRCCs) and papillary RCCs via 3p deletion/LOH and deleterious mutations. Histone H3-K36 trimethylation is facilitated by SETD2, which is necessary for proper pre-mRNA intron splicing. Improperly spliced mature mRNA may lead to aberrant translation of retained introns (ATaRI), which represents potential therapeutic vulnerabilities. We explored this hypothesis using real world data and RCC models. Methods and Results: Gene set enrichment analysis comparing SETD2-mutant to WT tumors using samples from the TCGA KIRC data set revealed that the unfolded protein response (UPR) was strongly enriched, as well as several immunotherapy-relevant pathways. This suggested that peptides arising from ATaRI may be present, since they would not be expected to fold properly and thus need to be addressed by the UPR pathway to maintain homeostasis. To investigate this further, we generated Setd2-isogenic RENCA cells using CRISPR. Knockout was confirmed by sequencing and immunoblot. H3K36 trimethylation was decreased or eliminated in monoclonal knockout cell lines, confirming a functional effect. Markers of UPR activation, including Atf4 and cleaved Atf6, were found to be upregulated in Setd2-mutant RENCA cells compared to controls as measured by immunoblot. Cleaved ATF6 translocates to the nucleus to induce the UPR transcriptional program. Consistent with this, Atf6 was found to localize to the nucleus in Setd2-knockout cells using immunofluorescence (IF). Analysis of tissue microarrays of human SETD2-mutant vs -WT ccRCC revealed increased ATF6 signal in areas with low H3K36 tri-methylation, indicating UPR activation in vivo. Interestingly, CHOP, another downstream effector of the UPR pathway which predominantly regulates cell death, did not become upregulated in Setd2-knockout cells, suggesting activation of a compensatory cell survival pathway. Geldanamycin was shown to destabilize the Perk and Ire1a arms of the UPR, which resulted in increased cell death in Setd2 mutant cells using Cell Titre glo. Additionally, H3K36 trimethylation has been implicated in directing homologous repair of DNA, and blunted responses to agents that induce DNA double-strand breaks of p-Atm, p53, and Rad51 were observed by immunoblot and IF. The inability to detect DNA damage in Setd2 mutant cells however did not confer sensitivity to PARP inhibitors. Conclusions: We identify activation of the UPR upon Setd2 loss and suggest that activation of part of the UPR pathway may represent a new therapeutic vulnerability for exploitation as a rationale for personalized medicine. We further characterize the altered DNA damage response in the setting of Setd2 loss. We continue to evaluate the generation of peptides arising from ATaRI in Setd2-mutant contexts. Citation Format: Alexander Metz, Marya Kozinova, Robert Uzzo, Jessica Peskin, Michael Slifker, Janusz Franco-Barraza, Edna Cukierman, Philip Abbosh. SETD2 loss in renal carcinoma cells induces the unfolded protein response [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 3725." @default.
• W4282936139 created "2022-06-16" @default.
• W4282936139 creator A5011122559 @default.
• W4282936139 creator A5016152141 @default.
• W4282936139 creator A5027615447 @default.
• W4282936139 creator A5030049527 @default.
• W4282936139 creator A5030888622 @default.
• W4282936139 creator A5038454044 @default.
• W4282936139 creator A5064946728 @default.
• W4282936139 creator A5072341738 @default.
• W4282936139 date "2022-06-15" @default.
• W4282936139 modified "2023-10-07" @default.
• W4282936139 title "Abstract 3725: <i>SETD2</i> loss in renal carcinoma cells induces the unfolded protein response" @default.
• W4282936139 doi "https://doi.org/10.1158/1538-7445.am2022-3725" @default.
• W4282936139 hasPublicationYear "2022" @default.
• W4282936139 type Work @default.
• W4282936139 citedByCount "0" @default.
• W4282936139 crossrefType "journal-article" @default.
• W4282936139 hasAuthorship W4282936139A5011122559 @default.
• W4282936139 hasAuthorship W4282936139A5016152141 @default.
• W4282936139 hasAuthorship W4282936139A5027615447 @default.
• W4282936139 hasAuthorship W4282936139A5030049527 @default.
• W4282936139 hasAuthorship W4282936139A5030888622 @default.
• W4282936139 hasAuthorship W4282936139A5038454044 @default.
• W4282936139 hasAuthorship W4282936139A5064946728 @default.
• W4282936139 hasAuthorship W4282936139A5072341738 @default.
• W4282936139 hasConcept C104317684 @default.
• W4282936139 hasConcept C139447449 @default.
• W4282936139 hasConcept C150194340 @default.
• W4282936139 hasConcept C150425827 @default.
• W4282936139 hasConcept C153911025 @default.
• W4282936139 hasConcept C158617107 @default.
• W4282936139 hasConcept C162317418 @default.
• W4282936139 hasConcept C2776745794 @default.
• W4282936139 hasConcept C502942594 @default.
• W4282936139 hasConcept C54355233 @default.
• W4282936139 hasConcept C64927066 @default.
• W4282936139 hasConcept C77957584 @default.
• W4282936139 hasConcept C86803240 @default.
• W4282936139 hasConcept C95444343 @default.
• W4282936139 hasConceptScore W4282936139C104317684 @default.
• W4282936139 hasConceptScore W4282936139C139447449 @default.
• W4282936139 hasConceptScore W4282936139C150194340 @default.
• W4282936139 hasConceptScore W4282936139C150425827 @default.
• W4282936139 hasConceptScore W4282936139C153911025 @default.
• W4282936139 hasConceptScore W4282936139C158617107 @default.
• W4282936139 hasConceptScore W4282936139C162317418 @default.
• W4282936139 hasConceptScore W4282936139C2776745794 @default.
• W4282936139 hasConceptScore W4282936139C502942594 @default.
• W4282936139 hasConceptScore W4282936139C54355233 @default.
• W4282936139 hasConceptScore W4282936139C64927066 @default.
• W4282936139 hasConceptScore W4282936139C77957584 @default.
• W4282936139 hasConceptScore W4282936139C86803240 @default.
• W4282936139 hasConceptScore W4282936139C95444343 @default.
• W4282936139 hasIssue "12_Supplement" @default.
• W4282936139 hasLocation W42829361391 @default.
• W4282936139 hasOpenAccess W4282936139 @default.
• W4282936139 hasPrimaryLocation W42829361391 @default.
• W4282936139 hasRelatedWork W1969232820 @default.
• W4282936139 hasRelatedWork W1992868516 @default.
• W4282936139 hasRelatedWork W2020080372 @default.
• W4282936139 hasRelatedWork W2033027341 @default.
• W4282936139 hasRelatedWork W2049868369 @default.
• W4282936139 hasRelatedWork W2092618826 @default.
• W4282936139 hasRelatedWork W2146501674 @default.
• W4282936139 hasRelatedWork W2298656647 @default.
• W4282936139 hasRelatedWork W2397424403 @default.
• W4282936139 hasRelatedWork W4211084604 @default.
• W4282936139 hasVolume "82" @default.
• W4282936139 isParatext "false" @default.
• W4282936139 isRetracted "false" @default.
• W4282936139 workType "article" @default.